Search
03/04/2021
NEWS PROVIDED BY GO2 Foundation for Lung Cancer
SAN CARLOS, Calif. and WASHINGTON, March 4, 2021 /PRNewswire/ -- GO2 Foundation for Lung Cancer (GO2 Foundation) announced its leadership in the…
03/01/2021
Blue Earth Diagnostics utilizing ERT imaging solution to evaluate a novel imaging agent for potential use to inform brain metastases disease management
02/23/2021
Earlier this year, the Busch Clinic added Profound Medical’s TULSA system to its treatment options. TULSA, also called “inside-out” ablation, uses a unique cooling system to provide thermal protection of important anatomy.
02/18/2021
Pavan Khanna, MD, discusses the evolution of Y-90 for the treatment of HCC and reviews the LEGACY and DOSISPHERE trials, which highlight how TheraSphere™ is progressing Y-90 therapy towards more advanced dosimetry techniques and personalization.
02/17/2021
LONDON, Feb. 17, 2021 /PRNewswire/ -- Theragnostics, which is developing molecular radiotherapy for imaging and treating a broad range of cancers, today announces a research collaboration with Essen University Hospital to examine Theragnostics' investigational agent THG-008 for PET imaging in a range of cancers.
02/05/2021
Digital Liver Cancer Summit 2021: A global survey assessing the impact of COVID-19 on liver cancer has revealed delays in the screening, diagnosis, and treatment of the disease, with experts issuing stark warnings on liver cancer survival rates.
02/02/2021
Join us in Miami for the practical IO meeting of the year!
Back to Top